Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
Amdocs
DOX
$6.18B
| $2.89M | ﹤0.01% |
34,671
-175,496
| -84% | -$14.5M |
|
4727
CALL
Veracyte
VCYT
$3.32B
| $2.89M | ﹤0.01% |
145,000
+126,300
| +675% | +$2.55M |
|
4728
CALL
West Fraser Timber
WFG
$5.54B
| $2.88M | ﹤0.01% |
37,600
-500
| -1% | -$42.1K |
|
|
HIBB
4729
CALL
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $2.88M | ﹤0.01% |
66,000
+35,300
| +115% | +$1.63M |
|
4730
Onto Innovation
ONTO
$20.3B
| $2.88M | ﹤0.01% |
41,350
+7,666
| +23% | +$567K |
|
|
PENG
4731
PUT
Penguin Solutions Inc
PENG
$3.27B
| $2.88M | ﹤0.01% |
176,200
-52,600
| -23% | -$1.2M |
|
|
HTO
4732
H2O America
HTO
$2.67B
| $2.88M | ﹤0.01% |
46,169
+24,783
| +116% | +$1.53M |
|
|
STOR
4733
CALL
DELISTED
STORE Capital Corporation
STOR
| $2.88M | ﹤0.01% |
110,500
-18,000
| -14% | -$498K |
|
4734
CALL
Brookfield Renewable
BEP
$10.4B
| $2.88M | ﹤0.01% |
82,800
+13,400
| +19% | +$482K |
|
|
SRG
4735
CALL
Seritage Growth Properties
SRG
$128M
| $2.88M | ﹤0.01% |
552,800
+309,900
| +128% | +$2.76M |
|
|
NVRO
4736
CALL
DELISTED
NEVRO CORP.
NVRO
| $2.88M | ﹤0.01% |
65,700
-1,200
| -2% | -$66K |
|
4737
Vanguard Total World Stock ETF
VT
$81.8B
| $2.88M | ﹤0.01% |
33,728
+8,705
| +35% | +$805K |
|
4738
PUT
Teledyne Technologies
TDY
$31.5B
| $2.87M | ﹤0.01% |
7,663
+4,286
| +127% | +$1.79M |
|
|
WHWK
4739
Whitehawk Therapeutics
WHWK
$254M
| $2.87M | ﹤0.01% |
233,255
-1,256
| -0.5% | -$18.7K |
|
|
BCPC
4740
Balchem Corp
BCPC
$5.69B
| $2.87M | ﹤0.01% |
+22,112
| New | +$2.77M |
|
4741
Hershey
HSY
$37B
| $2.87M | ﹤0.01% |
13,328
-311,078
| -96% | -$67.8M |
|
4742
PUT
ProShares Ultra Silver
AGQ
$1.43B
| $2.87M | ﹤0.01% |
117,100
+6,300
| +6% | +$198K |
|
4743
Genius Sports
GENI
$2.33B
| $2.87M | ﹤0.01% |
1,273,365
+68,655
| +6% | +$232K |
|
4744
CALL
Murphy USA
MUSA
$10.5B
| $2.86M | ﹤0.01% |
12,300
+8,200
| +200% | +$1.93M |
|
4745
Direxion Daily Technology Bear 3x ETF
TECS
$59.6M
| $2.86M | ﹤0.01% |
573
+247
| +76% | +$1.06M |
|
4746
CALL
LegalZoom.com
LZ
$963M
| $2.86M | ﹤0.01% |
260,400
+137,600
| +112% | +$1.82M |
|
4747
Molina Healthcare
MOH
$11.1B
| $2.86M | ﹤0.01% |
+10,237
| New | +$3.09M |
|
4748
State Street SPDR MSCI ACWI Climate Paris Aligned ETF
NZAC
$199M
| $2.86M | ﹤0.01% |
109,524
-14,572
| -12% | -$412K |
|
4749
CALL
Veru
VERU
$46.5M
| $2.86M | ﹤0.01% |
25,290
+18,180
| +256% | +$2.11M |
|
4750
PUT
United States Copper Index Fund
CPER
$774M
| $2.86M | ﹤0.01% |
128,600
+81,300
| +172% | +$2.13M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.